Criteria used as constraints during modeling |
|
|
|
|
192–270 |
E1 |
Homology model based on structures reported under PDB accession no. 4UOI and 1LN2
|
Crystallography |
20, 34
|
421–645 |
E2 |
Same as structure reported under PDB accession no. 4MWF
|
Crystallography |
19 |
C652, C677 |
E2 |
Disulfide bonded |
Ab binding patterns upon mutation |
32 |
352–378, 716–738 |
E1/E2 |
Single-domain helices |
NMR; fluorescent imaging of epitope-tagged C termini |
28, 29
|
K370, D728 |
E1/E2 |
Salt bridge between TMDs of E1 and E2 |
Mutational analysis |
29, 54–56
|
Criteria used to guide de novo model selection |
|
|
|
|
201–206, 639, 657–659, 692, 698 |
E1/E2 |
Residues are proximal to each other |
Required for binding to E1/E2 by AR4A and/or AR5A Abs |
18 |
315–324, 333–338, 693–701, 713–717 |
E1/E2 |
Two α-helices exist in each of E1 and E2 stem domains |
NMR studies of peptides |
38, 50
|
Agreement with expt observed after modeling |
|
|
|
|
192–238 |
E1 |
Near E1/E2 interface |
Peptide binds to E2 |
35 |
271–304 |
E1 |
Extension of structural homology of E1 to structure reported under PDB accession no. 1LN2
|
Crystallography |
34 |
H352 |
E1 |
Important for heterodimerization |
Mutational analysis |
58 |
480–487, 574–579 |
E2 |
HVR2 (residues 461–481), residues 484–491, and IgVR (residues 570–580) are essential for heterodimerization |
Studies of deletion constructs |
35, 59
|
541–548 |
E2 |
Near E1/E2 interface |
Mutations of residues 523–545 affect binding to E1/E2 by E1-specific Ab A7 |
18 |
587, 651–703 |
E2 |
5-residue insertions at residue 587 or 692 affect heterodimerization |
Linker-scanning mutagenesis |
60 |
L675, S678, H691 |
E2 |
L675, S678, and H691 are all determinants of heterodimerization |
Mutational analysis |
57 |